Recurv Pharma

Recent Finacing

Equity

Recent Raise

$24M

Recurv Pharma is a biotech developing RP-001, a novel taxane nano-emulsion designed to concentrate tumor delivery, address multi-drug resistant cancers, target cancer stem cells, and advance to Phase 2a.

Founded 2022

Delaware, United States

Private

Highlights

Focus Areas

Life Science

Pharmaceutical

Therapeutics

Recent Investors

Financials

$24M

Total Raised

1

Funding round

1

Investor

Team

Upgrade to view the team

See the team members at Recurv Pharma.